Abe K, Ishikawa Y, Kita Y, Yajima N, Inoue E, Sada K, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M: Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study. Arthritis Research & Therapy, 24: 179, 2022.
Hayashi K, Sada K, Asano Y, Katayama Y, Ohashi K, Morishita M, Miyawaki Y, Watanabe H, Katsuyama T, Narazaki M, Matsumoto Y, Yajima N, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Wada J: Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA). PLoS One, 17: e0270569, 2022.
Hidekawa C, Yoshimi R, Kishimoto D, Kato H, Mitsuhashi M, Sakurai N, Sato Y, Uehara T, Iizuka Y, Komiya T, Hamada N, Nagai H, Soejima Y, Kamiyama R, Takase-Minegishi K, Kirino Y, Sakagami T, Nakajima H: Anti-interferon-γ antibody-seropositive disseminated nontuberculous mycobacterial infection mimicking POEMS and TAFRO syndromes: a case report. Internal Medicine, 61: 2377-2385, 2022.
Higashitani K, Yoshimi R, Sato Y, Watanabe T, Ihata A: Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis. Modern Rheumatology Case Reports, 6: 87-92, 2022.
Higashitani K, Takase-Minegishi K, Yoshimi R, Kirino Y, Hamada N, Nagai H, Hagihara M, Matsumoto K, Namkoong H, Horita N, Nakajima H: Benefits and risks of hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis. Modern Rheumatology, 2022. (In press)
Hirahara L, Takase-Minegishi K, Kirino Y, Iizuka-Iribe Y, Soejima Y, Yoshimi R, Nakajima H: The roles of monocytes and macrophages in Behçet’s disease with focus on M1 and M2 polarization. Frontiers in Immunology, 13: 852297, 2022.
Iizuka Y, Takase-Minegishi K, Hirahara L, Kirino Y, Soejima Y, Namkoong H, Horita N, Yoshimi R, Takeuchi M, Takeno M, Mizuki N, Nakajima H: Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis. Modern Rheumatology, 32: 1153-1162, 2022.
Itagane M, Teruya H, Kato T, Tsuchida N, Maeda A, Uchiyama Y, Kirino Y, Matsumoto N, Kinjo M. VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa. Arthritis & Rheumatology, 74(11): 1863-1864, 2022.
Koga T, Sato S, Hagimori N, Yamamoto H, Ishimura M, Yasumi T, Kirino Y, Ikeda K, Yachie A, Migita K, Kishida D, Atsumi T, Kawakami A. A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever. Clinical and Experimental Rheumatology, 40(8):1535-1542, 2022.
Kunishita Y, Kirino Y, Tsuchida N, Maeda A, Sato Y, Takase-Minegishi K, Yoshimi R, Nakajima H: Case report: Tocilizumab treatment for VEXAS syndrome with relapsing polychondritis: A single-center, 1-year longitudinal observational study in Japan. Frontiers in Immunology, 13: 901063, 2022.
Maeda A, Takase-Minegishi K, Kirino Y, Hamada N, Kunishita Y, Yoshimi R, Meguro A, Namkoong H, Horita N, Nakajima H: YCU irAE working group. Immune checkpoint inhibitor-induced arthralgia is tightly associated with improved overall survival in cancer patients. Rheumatology (Oxford). keac519, 2022.
Matsubara A, Tsuchida N, Sakurai M, Maeda A, Uchiyama Y, Sasaki K, Haji Y, Kirino Y, Matsumoto N, Morita A: A case of VEXAS syndrome with Sweet’s disease and pulmonary involvement. the Journal of Dermatology, 49(5): e177-e178, 2022.
Matsumoto H, Fujita Y, Fukatsu M, Ikezoe T, Yokose K, Asano T, Tsuchida N, Maeda A, Yoshida S, Hashimoto H, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Murakami M, Sato H, Sakuma C, Kawashima K, Shakespear N, Uchiyama Y, Watanabe H, Kirino Y, Matsumoto N, Migita K: Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome. Frontiers in Immunology, 13: 897722, 2022.
Matsumoto H, Asano T, Tsuchida N, Maeda A, Yoshida S, Yokose K, Fujita Y, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Irie K, Norikawa N, Yamamoto T, Endo M, Fukuchi K, Ohkawara H, Ikezoe T, Uchiyama Y, Kirino Y, Matsumoto N, Watanabe H, Migita K: Behçet’s disease with a somatic UBA1 variant: Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome. Clinical Immunology, 238:108996, 2022.
Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N: Behçet’s disease and activities of daily living. Rheumatology (Oxford), 61: 1133-1140, 2022.
Oka S, Higuchi T, Furukawa H, Shimada K, Hashimoto A, Komiya A, Matsui T, Fukui N, Suematsu E, Ohno S, Kono H, Katayama M, Nagaoka S, Migita K, Tohma S: Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease. Sci Rep, 12(1):9916, 2022.
Sada K, Katayama Y, Asano Y, Hayashi K, Miyawaki Y, Ohashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yajima N: Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study. Lupus Science & Medicine, 9: e000772, 2022.
Uchino K, Kanasugi J, Enomoto M, Kitamura F, Tsuchida N, Uchiyama Y, Maeda A, Kirino Y, Matsumoto N, Takami A. VEXAS syndrome. International Journal of Hematology, 116(4):463-464, 2022.
Yamaguchi H, Kobayashi D, Nakamura G, Aida R, Horii Y, Okamoto T, Murakami S, Kondo D, Tsuchida N, Uchiyama Y, Maeda A, Kirino Y, Matsumoto N, Kurosawa Y, Hasegawa E, Wakamatsu A, Narita I: Acute heart failure due to left common iliac arteriovenous fistula: A case of VEXAS syndrome. Modern Rheumatology Case Reports, 2022.
